Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-α-receptors by inducing G0/G1 arrest but not apoptosis: A new model for dissecting cell-cycle arrest and apoptosis

Leukemia

Volumn 10, Issue 12, 1996, Pages 1950-1958

  Kuroki, J ^a   Hirokawa, M ^a   Kitabayashi, A ^a   Lee, M ^a   Horiuchi, T ^a   Kawabata, Y ^a   Miura, A B ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B lymphoma cells; Cell cycle arrest; Ceramide

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C INHIBITOR; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CELL STRAIN HL 60; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG MECHANISM; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAJI CELL;

EID: 0030479830     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-945.
2. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584-588.
3. Elias L, Moore PB, Rose SM. Tumor necrosis factor induced DNA fragmentation of HL-60 cells. Biochem Biophys Res Commun 1988; 157: 963-969.
4. Kim MY, Linardic CM, Obeid LM, Hannun YA. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon. J Biol Chem 1991; 265: 484-489.
5. Dressler KA, Mathias S, Kolesnick RN. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 1992; 255: 1715-1718.
6. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259: 1769-1771.
7. Pushkareva M, Obeid LM, Hannun YA. Ceramide: an endogenous regulator of apoptosis and growth suppression, Immunol Today 1995; 16: 294-297.
8. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Zvi, Kolesnick RN. Ionising radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180: 525-535.
9. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 23: 5036-5041.
10. Brockhaus M, Schoenfeld HI, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127-3131.
11. Hirokawa M, Gray JD, Takahashi T, Horwitz DA. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation. J Immunol 1992; 149: 1859-1866.
12. Martin SJ, Lennon SV, Bonham AM, Cotter TC. Induction of apoptosis (programmed cell deathl in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145: 1859-1867.
13. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kränke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 1992; 71: 765-776.
14. Kitabayashi A, Hirokawa M, Miura AB. The role of interleukin-10 (IL-10) in chronic B-lymphocytic leukemia: IL-10 prevents leukemic cells from apoptotic cell death, Int J Hematol 1995; 62: 99-106.
15. Hirokawa M, Kitabayashi A, Kuroki J, Miura AB. Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3. Immunology 1995; 86: 155-161.
16. Hirokawa M, Kuroki J, Kitabayashi A, Miura AB. Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation. Immunol Lett 1996; 50: 95-98.
17. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115: 61-69.
18. Greenblatt MS, Elias L. The type B receptor for tumor necrosis factor-á mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells. Blood 1992; 80: 1339-1346.
19. Baglioni C, McCandless S, Tavernier J, Fiers W. Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem 1985; 260: 13395-13397.
20. Yang Z, Costanzo M, Colde DW, Kolesnick RN. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor κB translocation in intact HL-60 cells. J Biol Chem 1993; 268: 20520-20523.
21. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992; 80: 459-469.
22. Guillouf C, Grana X, Selvakumaran M, Luca AD, Giordano A, Huffman B, Liebermann DA. Dissection of the genetic programs of p53-mediated G1 arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 1995; 85: 2691-2698.
23. Naumovski L, Cleary ML. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 1994; 83: 2261-2267.
24. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
25. Broome HE, Dargan CM, Krajewski S, Reed JC. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 1995; 155: 2311-2317.
26. Danova M, Giordano M, Mazzini G, Riccardi A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk Res 1990; 14: 417-422.
27. Mercer WE, Baserga R. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes, Exp Cell Res 1985; 160: 31-46.
28. Dbaibo GS, Pushkareva MY, Jayadev S, Schwarz JK, Horowitz JM, Obeid LM, Hannun YA. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 1995; 92: 1347-1351.
29. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva MY, Obeid LM, Hannun YA. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270: 2047-2052.
30. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
31. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995; 80: 285-291.
32. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995; 374: 731-733.
33. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor a and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 1989; 86: 2336-2340.
34. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308.
35. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77: 325-328.
36. Okazaki T, Bielawska A, Bell RM, Hannun YA. Role of ceramide as a lipid second mediator of 1α, 25-dehydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 1990; 265: 15823-15831.
37. Joseph CK, Byun H-S, Bittman R, Kolesnick RN. Substrate recognition by ceramide-activated protein kinase: evidence that kinase activity is praline-directed. J Biol Chem 1993; 268:20002-20006.
38. Liu J, Mathias S, Yang Z, Kolesnick RN. Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 1994; 269: 3047-3052.
39. Raines MA, Kolesnick RN, Golde DW. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993; 268: 14572-14575.
40. Liscovitch M, Cantley LC. Lipid second messengers. Cell 1994; 77:329-334.
41. Jayadev S, Linardic CM, Hannun YA. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem 1994; 269: 5757-5763.